Osteoblast-n-osteoclast: making headway to osteoporosis treatment
Background: Bone is a dynamic tissue that continuously undergoes the modeling and
remodeling process to maintain its strength and firmness. Bone remodeling is determined by …
remodeling process to maintain its strength and firmness. Bone remodeling is determined by …
The Genus Eriosema (Fabaceae): From the Ethnopharmacology to an Evidence-Based Phytotherapeutic Perspective?
SB Ateba, D Njamen, L Krenn - Frontiers in Pharmacology, 2021 - frontiersin.org
The genus Eriosema (Fabaceae) includes approximately 150 species widely distributed
across tropical and subtropical regions of the world (Africa, Neotropics, Asia and Australia) …
across tropical and subtropical regions of the world (Africa, Neotropics, Asia and Australia) …
Efficacy, Mechanism, and Structure–Activity Relationship of 6-Methoxy Benzofuran Derivatives as a Useful Tool for Senile Osteoporosis
Z Zhou, L Sun, X Han, Y Wang, Z Xie… - Journal of Medicinal …, 2023 - ACS Publications
Most patients with senile osteoporosis (SOP) are severely deficient in bone mass, and
treatments using bone resorption inhibitors, such as bisphosphonates, have shown limited …
treatments using bone resorption inhibitors, such as bisphosphonates, have shown limited …
Psoralen prevents the inactivation of estradiol and treats osteoporosis via covalently targeting HSD17B2
Y Lu, M Zhang, J Zhang, M Jiang, G Bai - Journal of Ethnopharmacology, 2023 - Elsevier
Ethnopharmacological relevance Psoralea corylifolia L. seeds (P. corylifolia), popularly
known as Buguzhi in traditional Chinese medicine, are often used to treat osteoporosis in …
known as Buguzhi in traditional Chinese medicine, are often used to treat osteoporosis in …
Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle …
Treating estrogen-dependent diseases like endometriosis with drugs suppressing local
estrogen activation may be superior to existing endocrine therapies. Steroid sulfatase (STS) …
estrogen activation may be superior to existing endocrine therapies. Steroid sulfatase (STS) …
SNAr or Sulfonylation? Chemoselective Amination of Halo(het)arene Sulfonyl Halides for Synthetic Applications and Ultralarge Compound Library Design
V Naumchyk, VA Andriashvili… - The Journal of …, 2024 - ACS Publications
The chemoselectivity of halo (het) arene sulfonyl halide aminations is studied thoroughly
under parallel synthesis conditions, and the scope and limitations of the method are …
under parallel synthesis conditions, and the scope and limitations of the method are …
[HTML][HTML] Recent advances in the development of 17beta-hydroxysteroid dehydrogenase inhibitors
D Poirier - Steroids, 2024 - Elsevier
The family of 17β-hydroxysteroid dehydrogenases (17β-HSDs) occupies a prominent place
due to its number of isoforms, which carry out a bidirectional transformation (reduction of a …
due to its number of isoforms, which carry out a bidirectional transformation (reduction of a …
17β-Hydroxysteroid dehydrogenases types 1 and 2: Enzymatic assays based on radiometric and mass-spectrometric detection
M Sinreih, M Gjorgoska, G Möller, J Adamski… - Methods in …, 2023 - Elsevier
The 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) has a key role in estrogen
biosynthesis as it catalyzes the reduction of estrone to the most potent estrogen, estradiol …
biosynthesis as it catalyzes the reduction of estrone to the most potent estrogen, estradiol …
Effects of 17β-HSD2 inhibition in bones on osteoporosis based on an animal rat model
ST Müller, S Pählig, A Merabet, AS Abdelsamie… - The Journal of Steroid …, 2019 - Elsevier
Hormone replacement therapy is a viable option to protect bone from postmenopausal
osteoporosis. Systemically elevated estrogen levels, however, are disadvantageous …
osteoporosis. Systemically elevated estrogen levels, however, are disadvantageous …
Entwicklung von 17β-HSD2-Inhibitoren mit und ohne Strukturelement für das Knochen-Targeting
A Merabet - 2022 - publikationen.sulb.uni-saarland.de
Osteoporose ist eine systemische Erkrankung des skelettalen Apparates und äußert sich in
einer Degression der Knochendichte und in der Mikroarchitektur des Knochengewebes. Die …
einer Degression der Knochendichte und in der Mikroarchitektur des Knochengewebes. Die …